Sign Up Today and Learn More About Strata Oncology Stock
Invest in or calculate the value of your shares in Strata Oncology or other pre-IPO companies through EquityZen's platform.
Strata Oncology Stock (STON)
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
About Strata Oncology Stock
Founded
2016
Headquarters
Ann Arbor, MI, US
Industries
Science and Engineering, Health Care, Biotechnology
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Strata Oncology Press Mentions
Stay in the know about the latest news on Strata Oncology
Precision Oncology Market Size is Valued to Soar USD 258.35 Billion by 2032
biospace • Jun 05, 2024
New data on ADC-TRS biomarker at ASCO | Strata Oncology posted on the topic
linkedin • Jun 05, 2024
Transforming Cancer Care: The Precision Oncology Market to Achieve 9.8% CAGR through 2032
pharmiweb • Jun 05, 2024
Global Precision Oncology Market Size To Exceed USA 260.5 Billion By 2033 | CAGR Of 10.21%
finance • Jun 05, 2024
Cancer biomarkers for immune checkpoint inhibitors
patents • Apr 13, 2024
Investors in Strata Oncology
Discover investors in Strata Oncology stock and explore their portfolio companies
Strata Oncology Management
Leadership team at Strata Oncology
Co-founder & CEO
Dan Rhodes
Chief Medical Officer, Co-Founder
Scott Tomlins
Join now and verify your accreditation status to gain access to:
- Strata Oncology current valuation
- Strata Oncology stock price
- Available deals in Strata Oncology and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Strata Oncology stock?
Accredited investors can buy pre-IPO stock in companies like Strata Oncology through EquityZen funds. These investments are made available by existing Strata Oncology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Strata Oncology stock?
Shareholders can sell their Strata Oncology stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
